Linker sequence and applicability to protease-activated antibodies in tumor context have been recently described by Geiger et al., demonstrating a synergistic effect for the combination of the cleavage sites for MMP-2/9-matriptase compared to MatA site or MMP site linkers alone (21). The gene discussed is MMP2; the disease is neoplasm.